Table 3.
Patients’ clinical characteristics.
| CN | Gender | Age | W/H | CHD | Associated syndrome | Ventilation support | Inotropic support | Baseline Qp/Qs | Baseline Spo2 | Repair program | Concomitant percutaneous procedure |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 2.4 | 3.6/50 | Right-dominant partially imbalanced AVSD, Aortic CoA, s/p surgical PA band, and Aortic CoA repair | – | I | No | 2.2 | 100 | BiV | – |
| 2 | F | 1 | 3.9/48 | Taussig Bing anomaly, Aortic CoA Coronary artery anomaly Slightly dysplastic PV (Previously treated neonatal infection)a | – | NI | No | 2.8 | 93 | BiV | Ductal stenting, BAS |
| 3 | F | 0.4 | 2.7/47 | Subaortic stenosis, Aortic CoA, VSD Borderline LV | – | NI | No | 3.2 | 100 | Potential BiV | Ductal stenting |
| 4 | F | 2 | 2.7/43 | VSD, PDA, ASD | T18 | I | No | 2.9 | 99 | Palliative | – |
| 5 | M | 1.2 | 3.2/48 | AS, Aortic CoA, No VSD Borderline LV s/p AS ballooning, BAS (Transfer for another center)a | – | I | Yes | 1.8 | 99 | Potential BiV | Ductal stenting |
| 6 | M | 2.9 | 5/52 | VSD, ASD | – | NI | No | 3.5 | 100 | BiV | – |
| 7 | M | 2.4 | 3.6/53 | Complete balanced AVSD | – | NI | No | 3.2 | 100 | BiV | – |
| 8 | F | 0.4 | 2.9/49 | Taussig Bing anomaly | – | NI | No | 1.6 | 93 | BiV | BAS |
| 9 | F | 2.1 | 3.4/50 | VSD, PDA, ASD | T21 | NI | No | 3 | 100 | BiV | – |
| 10 | F | 2.4 | 2.2/43 | Multiple VSD, PDA | T18 | I | Yes | 3 | 97 | Palliative | – |
| 11 | F | 2.1 | 1.9/42 | VSD, PDA | T13 | I | Yes | 3.4 | 100 | Palliative | – |
| 12 | F | 1.1 | 2.4/49 | AVSD | T21 | NI | No | 4 | 100 | BiV | – |
| 13 | F | 0.9 | 3.9/53 | Complete AVSD, PDA s/p PDA ligation | T21 | I | Yes | 4 | 100 | BiV | – |
| 14 | F | 0.2 | 2.8/50 | HLHS (MA, AA) | – | I | Yes | N/A | 96 | UiV | Ductal stenting, BAS |
AA, aortic atresia; AS, aortic stenosis; ASD, atrial septal defect; AVSD, atrioventricular septal defect; BAS, balloon atrial septostomy; BiV, biventricular physiology; CHD, congenital heart disease; CN, case number; CoA, coarctation; HLHS, hypoplastic left heart syndrome; I, invasive; LV, left ventricle; LVOTO, left ventricular outflow tract obstruction; MA, mitral atresia; N/A, non-available; NI, non-invasive; PA, pulmonary artery; PDA, patent ductus arteriosus; PFR, pulmonary flow restrictor; PV, pulmonary valve; RV, right ventricle; S/P, status post; T, trisomy; UiV, univentricular physiology; VSD, ventricular septal defect; W/H, weight (Kg)/height (cm).
Reason for delayed intervention.